dr. tolaney on pembrolizumab plus eribulin in tnbc
Published 7 years ago • 369 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
3:26
dr. sara tolaney on eribulin plus pembrolizumab for metastatic triple-negative breast cancer
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:08
a study investigating pembrolizumab in combination with eribulin in tnbc
-
0:58
dr. nanda on pembrolizumab potential for tnbc
-
3:26
pd-1 therapy with eribulin for triple negative mbc
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:56
dr. schmid on benefit of pembrolizumab in patients with tnbc
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
2:02
sara m. tolaney, md, mph, on the efficacy & safety of combination eribulin pembrolizumab
-
6:55
additional advances in triple-negative breast cancer research and trials: sara m. tolaney, md, mph
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
1:13
dr. tolaney discusses patient selection for platinum-based therapy in tnbc
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
0:56
dr. nanda on immunotherapy in metastatic tnbc
-
0:56
dr. tolaney on recent advances in hr-positive breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer